Literature DB >> 26327517

Correction: A Five-Year Experience of Carbapenem Resistance in Enterobacteriaceae Causing Neonatal Septicaemia: Predominance of NDM-1.

Saswati Datta, Subhasree Roy, Somdatta Chatterjee, Anindya Saha, Barsha Sen, Titir Pal, Tapas Som, Sulagna Basu.   

Abstract

Entities:  

Year:  2015        PMID: 26327517      PMCID: PMC4556661          DOI: 10.1371/journal.pone.0134079

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
Gene names Ompk36 and Ompk35 are swapped incorrectly throughout the manuscript. All instances of Ompk35 should appear as Ompk36, and all instances of Ompk36 should appear as Ompk35. Corrected versions of Tables 3 and 4, which contain references to Ompk35, can be viewed below with the correct references to Ompk36.
Table 3

Microbiological and molecular characterization of non-NDM-harbouring Enterobacteriaceae isolates with ertapenem MIC ≥0.5 mg/L.

Isolate no.Period of isolationorganismMIC Values (mg/L)Genetic determinantsIntegronsPorins
CTETPMPAKGMCITGCCL
I1Mar, 2007 Klebsiella pneumoniae >2560.50.0948963ND # ND bla SHV-28, bla TEM-1, bla OXA-1, bla CTX-M-28 Ompk36, Omp A
I2Aug, 2007 Klebsiella pneumoniae >2560.50.09424134NDND bla SHV-61, bla TEM-1, bla OXA-1, bla CTXM-22 IntI1Ompk36, Omp A
I3Aug, 2007 Escherichia coli >2560.50.1916128>32NDND bla OXA-1, bla CTXM-28, rmt B Omp C, Omp A
I4Sep, 2007 Enterobacter cloacae >2560.50.19≥256≥1024>32NDND bla TEM-1, bla OXA-1, bla CTXM-15 Omp C, Omp A
I5Jan, 2008 Enterobacter cloacae >256240.2516≥1024>320.1250.25 bla TEM-1, bla OXA-1, bla CTXM-15, bla ACT-7 Omp C, Omp A
I6Sep, 2008 Klebsiella pneumoniae >2560.50.04712162>320.50.16 bla TEM-1, bla OXA-1, bla CTXM-15 IntI1Ompk36, Omp A
I7Dec, 2008 Escherichia coli >256>321≥256≥1024>320.0640.125 bla TEM-1, bla OXA-1, bla CTXM-15, bla CMY-4 IntI1Omp C, Omp A
I8Jan, 2009 Klebsiella pneumoniae >25620.19848>3281 bla SHV-11, bla TEM-1, bla OXA-1, bla CTXM-15 IntI1Ompk36, Omp A
I9Jul, 2009 Klebsiella pneumoniae >256320.1258128>3210.38 bla SHV-1, bla TEM-1, bla OXA-1, bla CTXM-15 IntI1Ompk36, Omp A
I10Aug, 2009 Klebsiella pneumoniae >25610.1252>1024>3210.25 bla SHV-1, bla TEM-1, bla OXA-1, bla CTXM-15 Ompk36, Omp A
I11Dec, 2009 Klebsiella pneumoniae >2560.50.3820.750.750.750.5 bla SHV-1 IntI1Ompk36, Omp A

CT: Cefotaxime, ETP: Ertapenem, MP: Meropenem, AK: Amikacin, GM: Gentamicin, CI: Ciprofloxacin, TGC: Tigecycline, CL: Colistin; IntI1: class 1 integron; Omp: Outer membrane protein.

# ND: Not Determined

Table 4

Antibiotic susceptibility and molecular characterization of NDM-1- harbouring Enterobacteriaceae along with clinical features of the neonates harbouring the same isolates in their blood specimens.

Patient no./Organism(isolate no.)SexInbornOrOutbornBirthweightGestationalAge $ ModeOfdeliveryventilationPrescribedantibioticsOutcomeMIC Values (mg/L)GeneticdeterminantsIntegronPorins
CTETPMPAKGMCITGCCL
P1/ Escherichia coli (E1)MInbornLBWpretermLUCSNoPipTaz/Amikadischarge>256>32>32>256>1024>320.251 bla TEM-1, bla CTXM-15,bla CMY-6, rmt C, aac(6’)-Ib, ble MBL IntI1Omp C, Omp A
P2/ Escherichia coli (E2)MInbornVLBWpretermLUCSYesPipTaz/Amikadischarge>256>328>256>1024>320.250.5 bla TEM-1, bla OXA-1, bla CMY-42, arm A, aac(6’)-Ib-cr, ble MBL Omp C, Omp F, Omp A
P3/ Klebsiella pneumoniae (K1)MOutbornNWtermNVDYescolistindischarge>256>3232>256>1024>320.750.25 bla SHV-11, aac(6’)-Ib, ble MBL IntI1Ompk36, Omp A
P4/ Klebsiella pneumoniae (K2)MOutbornLBWpretermLUCSNoofloxacindischarge>256>3224>256>102431.50.38 bla SHV-167, bla CTXM-15,arm A, aac(6’)-Ib-cr, ble MBL IntI1Ompk36, Omp A
P5/ Klebsiella pneumoniae (K3)MOutbornLBWpretermNVDYesofloxacindischarge>256124>256>1024>3210.75 bla TEM-1, bla OXA-1, bla CTXM-15, aac(6’)-Ib, ble MBL IntI1Ompk36, Omp A
P6/ Klebsiella pneumoniae (K4)MOutbornLBWtermLUCSYescolistindischarge>256>3232>256>1024>3210.38 bla TEM-1, bla OXA-1, bla CTXM-15, aac(6’)-Ib, ble MBL IntI1Ompk36, Omp A
P7/ Escherichia coli (E3)MInbornLBWpretermNVDNomeropenemdeath>256>3216>256>1024>320.250.38 bla TEM-1, bla CTXM-15, rmt B, ble MBL IntI1Omp C, Omp F, Omp A
P8/ Klebsiella pneumoniae (K5)FOutbornVLBWpretermLUCSYesmeropenemdischarge>256>3232>256>1024>320.380.75 bla SHV-11, bla OXA-1, bla CTXM-15, aac(6’)-Ib, ble MBL IntI1Ompk36, Omp A
P9/ Enterobacter cloacae (EC1)MOutbornLBWpretermNVDYescolistin/ofloxacinLAMA>256>32>32>256>102440.251.5 bla OXA-1, bla CTXM-15, bla ACT-16, rmt C, aac(6’)-Ib, ble MBL IntI1Omp C, Omp A
P10/ Enterobacter cloacae (EC2)* MOutbornVLBWpretermNVDYescolistindischarge>25686>256>102420.50.5 bla TEM-1, bla OXA-1, bla CTXM-15, rmt B, aac(6’)-Ib-cr, ble MBL IntI1Omp C, Omp A
P10/ Escherichia coli (E4)* MOutbornVLBWpretermNVDYescolistindischarge>256>32>32>256>1024>320.1250.75 bla TEM-1, bla CTXM-15, bla CMY-42, rmt B, ble MBL IntI1Omp C, Omp F, Omp A
P11/ Escherichia coli (E5)MInbornLBWtermLUCSNoofloxacindischarge>256>3232>256>1024>320.381.5 bla CTXM-15, rmt B, aac(6’)-Ib-cr, ble MBL IntI1Omp C, Omp F, Omp A
P12/ Klebsiella pneumoniae (K6)** No clinical data available>256124>256>102480.751 bla TEM-1, bla OXA-1, bla CTXM-15,rmt B,aac(6’)-Ib,ble MBL IntI1Ompk36,Omp A
P13/ Enterobacter cloacae (EC3)MOutbornVLBWpretermNVDYesPipTaz/Amikadeath>256>3232>256>102481.51 bla TEM-1, bla CTXM-15, aac(6’)-Ib, ble MBL IntI1Omp C, Omp A
P14/ Escherichia coli (E6)MOutbornVLBWpretermNVDNoofloxacindischarge>256>321.5>256>1024>320.0940.75 bla TEM-1, bla OXA-1, bla CTXM-15, bla CMY-42, rmt B, aac(6’)-Ib IntI1Omp C, Omp F, Omp A

M: male; F: female; LBW: low birth weight (<2500 gm); VLBW: very low birth weight (<1500 gm); NW: normal weight (>2500 gm); NVD: normal vaginal delivery; LUCS: low uterine caesarean delivery; Omp: Outer membrane protein; LAMA: left against medical advice.

CT: Cefotaxime; ETP: Ertapenem; MP: Meropenem; AK: Amikacin; GM: Gentamicin; CI: Ciprofloxacin; TGC: Tigecycline; CL: Colistin; PipTaz: Piperacillin/Tazobactam; Amika: Amikacin

$ Gestational age <37 weeks is considered as preterm.

*Two different Enterobacteriaceae isolates (1 E. coli and 1 E. cloacae) were isolated from blood of a single patient.

**No clinical data was available for this patient

CT: Cefotaxime, ETP: Ertapenem, MP: Meropenem, AK: Amikacin, GM: Gentamicin, CI: Ciprofloxacin, TGC: Tigecycline, CL: Colistin; IntI1: class 1 integron; Omp: Outer membrane protein. # ND: Not Determined M: male; F: female; LBW: low birth weight (<2500 gm); VLBW: very low birth weight (<1500 gm); NW: normal weight (>2500 gm); NVD: normal vaginal delivery; LUCS: low uterine caesarean delivery; Omp: Outer membrane protein; LAMA: left against medical advice. CT: Cefotaxime; ETP: Ertapenem; MP: Meropenem; AK: Amikacin; GM: Gentamicin; CI: Ciprofloxacin; TGC: Tigecycline; CL: Colistin; PipTaz: Piperacillin/Tazobactam; Amika: Amikacin $ Gestational age <37 weeks is considered as preterm. *Two different Enterobacteriaceae isolates (1 E. coli and 1 E. cloacae) were isolated from blood of a single patient. **No clinical data was available for this patient
  1 in total

1.  A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.

Authors:  Saswati Datta; Subhasree Roy; Somdatta Chatterjee; Anindya Saha; Barsha Sen; Titir Pal; Tapas Som; Sulagna Basu
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

  1 in total
  2 in total

1.  Transcriptional analysis of blaNDM-1 and copy number alteration under carbapenem stress.

Authors:  Deepjyoti Paul; Amitabha Bhattacharjee; Dibyojyoti Bhattacharjee; Debadatta Dhar; Anand Prakash Maurya; Atanu Chakravarty
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-20       Impact factor: 4.887

2.  Extended-spectrum β-lactamase & carbapenemase-producing Gram-negative bacilli in neonates from a tertiary care centre in Dibrugarh, Assam, India.

Authors:  Utpala Devi; Reeta Bora; Jayanta Kumar Das; Jagadish Mahanta
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.